2 Scopus citations

Abstract

DURECT Corp is developing Chronogesic, a subcutaneous implant (DUROS) formulation of the synthetic opioid analgesic sufentanil, for the potential treatment of chronic pain resulting from a variety of causes, including head and neck, lower back, arthritis and cancer pain.

Original languageEnglish (US)
Pages (from-to)368-371
Number of pages4
JournalIDrugs
Volume6
Issue number4
Publication statusPublished - Apr 1 2003

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology

Cite this

Joshi, G. P. (2003). Chronogesic DURECT. IDrugs, 6(4), 368-371.